A BIOCOMPATIBLE THERAPEUTIC PLATFORM FOR PRECISE REGULATION OF VASCULARIZED COMPOSITE ALLOTRANSPLANT REJECTION VIA ENHANCED COSTIMULATION BLOCKAGE

The Johns Hopkins University

Investigators